SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-140494
Filing Date
2014-04-11
Accepted
2014-04-11 16:08:59
Documents
6
Effectiveness Date
2014-04-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A d710804ddefa14a.htm DEFA14A 40990
2 GRAPHIC g710804arrow_x.jpg GRAPHIC 5420
3 GRAPHIC g710804tx_pg1.jpg GRAPHIC 4870
4 GRAPHIC g710804tx_pg2.jpg GRAPHIC 4909
5 GRAPHIC g710804tx_pg3.jpg GRAPHIC 4823
6 GRAPHIC g710804tx_pg4.jpg GRAPHIC 4901
  Complete submission text file 0001193125-14-140494.txt   77110
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35670 | Film No.: 14760043
SIC: 2834 Pharmaceutical Preparations